ALAB
Astera Labs, Inc. Common Stock
ALAB's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over ALAB overall, supported by stronger valuation and lower modeled downside.
ALAB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
ALAB's revenue, profitability, cash flow and balance sheet are all currently strong.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
ALAB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 33x | $228 | — |
| Cheap | 72x | $182 | -20% |
| Current | 91x | $228 | — |
| Fair | 108x | $272 | +19% |
| Expensive | 172x | $431 | +89% |
Historical ranges are pointers, not guarantees.
ALAB has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
ALAB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for ALAB, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
ALAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.88 | +174% |
| Q3 2026 | $2.51 | +14% |
| Q2 2026 | $2.02 | +22% |
| Q1 2026 | $1.48 | +13% |
| Q4 2025 | $1.22 | +$1.86 |
| Q3 2025 | $2.20 | +$3.98 |
| Q2 2025 | $1.65 | +$3.40 |
| Q1 2025 | $1.31 | +$3.16 |
| Q4 2024 | -$0.64 | -$0.43 |
ALAB earned $2.51 per share over the past year, up 14% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over ALAB on earnings, with more consistent year-over-year improvement.
ALAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $584.9M | +154% |
| Q2 2026 | $392.4M | +104% |
| Q1 2026 | $308.4M | +93% |
| Q4 2025 | $270.6M | +92% |
| Q3 2025 | $230.6M | +104% |
| Q2 2025 | $191.9M | +150% |
| Q1 2025 | $159.4M | +144% |
| Q4 2024 | $141.1M | +179% |
ALAB has the edge over MU on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +6.6 points |
| Q2 2026 | 23% | +2 points |
| Q1 2026 | 20% | +13 points |
| Q4 2025 | 25% | +25 points |
| Q3 2025 | 24% | +32 points |
| Q2 2025 | 21% | +52 points |
| Q1 2025 | 7.1% | +134 points |
| Q4 2024 | 0.1% | -18 points |
ALAB's operating margin was 31% last quarter, up 6.6 points from the same quarter a year ago, near the top of its range since 2022.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU's revenue has grown year over year for 12 quarters in a row: $54.2B last quarter, up 379% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over ALAB on profitability, with a higher operating margin.
ALAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $133.9M | +103% |
| Q2 2026 | $67.2M | -50% |
| Q1 2026 | $67M | +1023% |
| Q4 2025 | $76.6M | +216% |
| Q3 2025 | $65.9M | +41% |
| Q2 2025 | $133.3M | +328% |
| Q1 2025 | $6M | +2516% |
| Q4 2024 | $24.3M | +81% |
ALAB generated $345M in free cash flow over the past year, up 50% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU generated $59B in free cash flow over the past year, more than ten times what it generated the year before.
ALAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +737K shares |
| 1 year | +1.9% | +3.4M shares |
| 3 years | +21% | +31.6M shares |
ALAB has 184M diluted shares, up 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $210,000 |
| Q3 2023 | — |
| Q2 2023 | $118,000 |
| Q1 2023 | — |
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has the edge over ALAB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
ALAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -3.5x | Net Cash |
ALAB has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
ALAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 12.4 | Oversold |
ALAB's weekly RSI is 43 (neutral) and its Stochastic is 12 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
ALAB PE vs Technology Sector
| Metric | ALAB | Sector median | Relative |
|---|---|---|---|
| PE | 91x | 28x | 226% above |
| PE % | 33 | 17 | 16 pts above |
ALAB is trading at 91x earnings, a 226% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over ALAB on valuation relative to its sector.
ALAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $284.7 | 20% below |
| 20 week MA | $306.9 | 26% below |
| 50 week MA | $241.4 | 5.6% below |
| 100 week MA | $182.7 | 25% above |
MU has stronger trend alignment. ALAB is above 1 of 4 weekly averages versus MU above 3 of 5.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
ALAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $70.0 | $141.5 | +102% |
| 2025 | $141.5 | $167.3 | +18% |
| 2026 YTD | $167.3 | $227.8 | +36% |
ALAB has finished every year since 2024 higher, and it's up 36% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over ALAB on returns for 2026, with the stronger performance.